Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: II. BRCA1 and BRCA2
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide recommendations for cancer surveillance and risk reduction for individuals carrying mutations in the BRCA1 or BRCA2 genes. PARTICIPANTS: A task force with expertise in medical genetics, oncology, primary care, gastroenterology, and epidemiology convened by the Cancer Genetics Studies Consortium (CGSC), organized by National Human Genome Research Institute (previously the National Center for Human Genome Research). EVIDENCE: Studies evaluating cancer risk, surveillance, and risk reduction in individuals genetically susceptible to breast and ovarian cancer were identified using MEDLINE (National Library of Medicine) and from bibliographies of articles thus identified. Indexing terms used were "genetics" in combination with "breast cancer," "ovarian cancer," and "screening," or "surveillance" in combination with "cancer family" and "BRCA1" and "BRCA2." For studies evaluating specific interventions, quality of evidence was assessed using criteria of the US Preventive Services Task Force. CONSENSUS PROCESS: The task force developed recommendations through discussions over a 14-month period. CONCLUSIONS: Efficacy of cancer surveillance or other measures to reduce risk in individuals who carry cancer-predisposing mutations is unknown. Based on expert opinion concerning presumptive benefit, early breast cancer and ovarian cancer screening are recommended for individuals with BRCA1 mutations and early breast cancer screening for those with BRCA2 mutations. No rec…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Five women in the BPM Group (19%) and 3 in the UPM group (7%) had previously undergone prophylactic oophorectomy (removal of the ovaries to try to prevent ovarian cancer) which is recommended for consideration by BRCA1/2 mutation carriers [Burke 1997]. Eighteen of the women in the COPM group (49%) had had a prophylactic oophorectomy.”
From Support needs and acceptability of psychological and peer consultation: Attitudes of 108 women who had undergone or were considering prophylactic mastectomy (2008) · cites this paper as Burke 1997
In the citing paper
“Prophylactic mastectomy (PM) is one of the few evidence-based, risk-reducing options open to female carriers of BRCA1/2 mutations [Burke 1997;] [Nelson 2005]”
From Support needs and acceptability of psychological and peer consultation: Attitudes of 108 women who had undergone or were considering prophylactic mastectomy (2008) · cites this paper as Burke 1997
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer
Selby, J. V., Friedman, G. D., Quesenberry, C. P., & Weiss, N. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261001 · Cited by 1,702
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Reproductive Factors and Breast Cancer
Kelsey, J. L., Gammon, M. D., & John, E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036115 · Cited by 1,446
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Efficacy of screening mammography. A meta-analysis
Kerlikowske, K. M. (1995) · JAMA · doi:10.1001/jama.273.2.149 · Cited by 1,131
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Report of the International Workshop on Screening for Breast Cancer
Fletcher, S. W., Black, W., Harris, R., Rimer, B. K., & Shapiro, S. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1644 · Cited by 792
Burke, W. (1997) · JAMA · doi:10.1001/jama.1997.03540350065035 · Cited by 725
Self-citationPrognostic value of vascular endothelial growth factor expression in gastric carcinoma
Maeda, K., Chung, Y. S., Ogawa, Y., Kang, S., Ogawa, M., Sawada, T., & Sowa, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960301)77:5<934::aid-cncr20>3.0.co;2-3 · Cited by 639
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
Steinberg, K. K. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460150089030 · Cited by 626
Ovarian Cancer: Screening, Treatment, and Follow-up
Seltzer, V. (1995) · JAMA · doi:10.1001/jama.1995.03520300065039 · Cited by 580
Risk of endometrial cancer after tamoxifen treatment of breast cancer
van Leeuwen, F. E., van den Belt-Dusebout, A. W., van Leeuwen, F. E., Benraadt, J., Diepenhorst, F. W., van Tinteren, H., Coebergh, J. W. W., Kiemeney, L. A. L. M., Gimbrère, C. H. F., Otter, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92692-1 · Cited by 566
Diet, Body Size, and Breast Cancer
Hunter, D. J., & Willett, W. C. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036096 · Cited by 489
Physical Exercise and Reduced Risk of Breast Cancer in Young Women
Bernstein, L., Henderson, B. E., Hanisch, R., Sullivan-Halley, J., & Ross, R. K. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.18.1403 · Cited by 472
High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer
Johansson, J.-E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160049033 · Cited by 467
Jacobs, I., Davies, A. P., Bridges, J., Stabile, I., Fay, T., Lower, A., Grudzinskas, J. G., & Oram, D. (1993) · BMJ · doi:10.1136/bmj.306.6884.1030 · Cited by 360
INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES
Tobacman, J., Tucker, M., Kase, R., Greene, M., Costa, J., & Fraumeni, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92681-2 · Cited by 351
The epidemiology of cervical carcinogenesis
Schiffman, M. H., & Brinton, L. A. (1995) · Cancer · doi:10.1002/1097-0142(19951115)76:10+<1888::aid-cncr2820761305>3.0.co;2-h · Cited by 344
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Stanford, J. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530020055032 · Cited by 339
Beam, C. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440020119016 · Cited by 337
Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Mettlin, C., Jones, G., Averette, H., Gusberg, S. B., & Murphy, G. P. (1993) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.43.1.42 · Cited by 301
Genetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer
Biesecker, B. B. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150082032 · Cited by 300
Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians
Hoskins, K. F. (1995) · JAMA · doi:10.1001/jama.1995.03520310075033 · Cited by 294
Transabdominal ultrasound screening for early ovarian cancer.
Campbell, S., Bhan, V., Royston, P., Whitehead, M. I., & Collins, W. P. (1989) · BMJ · doi:10.1136/bmj.299.6712.1363 · Cited by 284
Prostate Cancer Screening: What We Know and What We Need To Know
Kramer, B. S., Brown, M. L., Prorok, P. C., Potosky, A. L., & Gohagan, J. K. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00009 · Cited by 273
Zurawski, V. R., Orjaseter, H., Andersen, A., & Jellum, E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420507 · Cited by 268
Breast Self-Examination Practices and Breast-Cancer Stage
Foster, R. S., Lang, S. P., Costanza, M. C., Worden, J. K., Haines, C. R., & Yates, J. W. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808102990601 · Cited by 265
The genetics of breast and ovarian cancer
Ford, D., & Easton, D. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.417 · Cited by 264
Collaborating NSABP Investigators, Fisher, E. R., Sass, R., & Fisher, B. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i · Cited by 250
Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies
Colditz, G. A., Egan, K. M., & Stampfer, M. J. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90784-4 · Cited by 246
Shattuck-Eidens, D. (1995) · JAMA · doi:10.1001/jama.1995.03520310033026 · Cited by 246
MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
Jacobs, I., Bridges, J., Reynolds, C., Stabile, I., Kemsley, P., Grudzinskas, J., & Oram, D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90351-0 · Cited by 241
Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
Woolf, S. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332107 · Cited by 240
Inherited breast and ovarian cancer. What are the risks? What are the choices?
King, M. (1993) · JAMA · doi:10.1001/jama.269.15.1975 · Cited by 236
Effect of Fecal Occult Blood Testing on Mortality from Colorectal Cancer: A Case–Control Study
Selby, J. V., Friedman, G. D., Quesenberry, Jr., & Weiss, N. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-1-199301010-00001 · Cited by 230
Greenwald, P., Nasca, P. C., Lawrence, C. E., Horton, J., McGarrah, R. P., Gabriele, T., & Carlton, K. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808102990602 · Cited by 228
Evaluation of adnexal masses with transvaginal color ultrasound.
Kurjak, A., Žalud, I., & Alfirević, Ž. (1991) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1991.10.6.295 · Cited by 218
A quantitative assessment of oral contraceptive use and risk of ovarian cancer
Hankinson, S., Colditz, G., Hunter, D., Spencer, T., Rosner, B., & Stampfer, M. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90732-c · Cited by 206
Inherited breast and ovarian cancer
Szabo, C., & King, M. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1811 · Cited by 203
Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F., Ponder, B. A. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-309 · Cited by 201
Screening for Prostate Cancer: A Decision Analytic View
Krahn, M. D. (1994) · JAMA · doi:10.1001/jama.1994.03520100035030 · Cited by 199
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing, J. P., Watson, P., Easton, D., Ponder, B. A. J., Lynch, H. T., & Tucker, M. A. (1995) · PubMed · Cited by 184
Intestinal metaplasia of the stomach. A status report
Stemmermann, G. N. (1994) · Cancer · doi:10.1002/1097-0142(19940715)74:2<556::aid-cncr2820740205>3.0.co;2-j · Cited by 177
Aminophylline for methotrexate-induced neurotoxicity
Bernini, J. C., Fort, D. W., Griener, J. C., Kane, B. J., Chappell, W. B., Kamen, B. A., & Kamen, B. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90464-6 · Cited by 163
Risk of Breast Cancer Among Young Women: Relationship to Induced Abortion
Daling, J. R., Malone, K. E., Voigt, L. F., White, E., & Weiss, N. S. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.21.1584 · Cited by 160
Detection and Surveillance of Colorectal Cancer
Ragozzino, M. W. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440030057017 · Cited by 158
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Guðmundsson, J., Jóhannesdóttir, G., Bergþorsson, J. Þ., Arason, A., Ingvarsson, S., Egilsson, V., & Barkardottir, R. B. (1995) · PubMed · Cited by 156
Should women with familial ovarian cancer undergo prophylactic oophorectomy?
Kerlikowske, K. M., Brown, J. S., & Grady, D. G. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90733-d · Cited by 148
Revision in American Cancer Society recommendations for the early detection of colorectal cancer
Levin, B., & Murphy, G. P. (1992) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.42.5.296 · Cited by 147
A cohort study of stomach cancer in a high-risk american population
Kneller, R. W., McLaughlin, J. K., Blot, W. J., Wacholder, S., Gridley, G., Fraumeni, J. F., Bjelke, E., Schuman, L. M., & Cochien, H. T. (1991) · Cancer · doi:10.1002/1097-0142(19910801)68:3<672::aid-cncr2820680339>3.0.co;2-t · Cited by 143
Kramer, B. S., Gohagan, J., Prorok, P. C., & Smart, C. (2010) · Cancer · doi:10.1002/cncr.2820710215 · Cited by 140
Physicians' Abilities to Detect Lumps in Silicone Breast Models
Fletcher, S. W. (1985) · JAMA · doi:10.1001/jama.1985.03350390066027 · Cited by 138
Long-term Hormone Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women
Newcomb, P. A., Longnecker, M. P., Storer, B. E., Mittendorf, R. L., Baron, J. A., Clapp, R., Bogdan, G., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117717 · Cited by 137
Subcutaneous mastectomy data: A final statistical analysis of 1500 patients
Pennisi, V. R., & Capozzi, A. (1989) · Aesthetic Plastic Surgery · doi:10.1007/bf01570320 · Cited by 137
Serum CA 125 levels in preoperative evaluation of pelvic masses.
Vasilev, S. A., Schlaerth, J. B., Campeau, J., & Morrow, C. P. (1988) · PubMed · Cited by 134
Alcohol Consumption and Risk of Breast Cancer: A Review of the Epidemiologic Evidence
Rosenberg, L., Metzger, L. S., & Palmer, J. R. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036097 · Cited by 128
Variability in the interpretation of screening mammograms by US radiologists
Beam, C. A., Ladge, P. M., & Sullivan, D. C. (1996) · Academic Radiology · doi:10.1016/s1076-6332(96)80282-0 · Cited by 124
Burhenne, H. J., Burhenne, L. J. W., Goldberg, F., Hislop, T. G., Worth, A. J., Rebbeck, P. M., & Kan, L. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.5.8165983 · Cited by 122
Ultrasound screening for familial ovarian cancer
Bourne, T., Whitehead, M. I., Campbell, S. C., Royston, P. J., Bhan, V., & Collins, W. P. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90051-6 · Cited by 121
The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
Gross, T. P., & Schlesselman, J. (1994) · PubMed · Cited by 119
Breast Self-Examination in Relation to the Occurrence of Advanced Breast Cancer
Newcomb, P. A., Weiss, N. S., Storer, B. E., Scholes, D., Young, B. E., & Voigt, L. F. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.4.260 · Cited by 114
Alcohol consumption and risk op breast cancer
Rohan, T. E., & McMichael, A. J. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410510 · Cited by 112
The woman at increased risk for breast cancer: evaluation and management strategies
Bilimoria, M. M., & Morrow, M. (1995) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.5.263 · Cited by 111
DNA Screening for Breast/Ovarian Cancer Susceptibility Based on Linked Markers: A Family Study
Lynch, H. T., Watson, P., Conway, T. A., Lynch, J. F., Slominski-Caster, S. M., Narod, S. A., Feunteun, J., & Lenoir, G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410170053005 · Cited by 111
Chromosome arm painting probes
Guan, X., Zhang, H., Bittner, M. L., Jiang, Y., Meltzer, P. S., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng0196-10 · Cited by 108
Failure of subcutaneous mastectomy to prevent the development of breast cancer
Goodnight, J. E., Quagliana, J. M., & Morton, D. L. (1984) · Journal of Surgical Oncology · doi:10.1002/jso.2930260313 · Cited by 108
Occurrence of Breast Cancer in Relation to Recreational Exercise in Women Age 50–64 Years
McTiernan, A., Stanford, J. L., Weiss, N. S., Daling, J. R., & Voigt, L. F. (1996) · Epidemiology · doi:10.1097/00001648-199611000-00006 · Cited by 107
SOME ANATOMICAL CONSIDERATIONS OF SUBCUTANEOUS MASTECTOMY
Goldman, L., & Goldwyn, R. M. (1973) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-197305000-00002 · Cited by 105
Radiation and Other Environmental Exposures and Breast Cancer
John, E. M., & Kelsey, J. L. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036099 · Cited by 97
Prospective Study of Serum CA-125 Levels as Markers of Ovarian Cancer
Helzlsouer, K. J. (1993) · JAMA · doi:10.1001/jama.1993.03500090059033 · Cited by 97
Profile of Women Practicing Breast Self-examination
Bennett, S. E., Lawrence, R. S., Fleischmann, K. H., Gifford, C. S., & Slack, W. V. (1983) · JAMA · doi:10.1001/jama.1983.03330280034025 · Cited by 92
Transvaginal sonography as a screening method for ovarian cancer
Higgins, R. V., van Nagell, J. R., Donaldson, E. S., Gallion, H. H., Pavlik, E. J., Endicott, B., & Woods, C. H. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90181-9 · Cited by 89
Cancer of the breast after prophylactic subcutaneous mastectomy
Eldar, S., Meguid, M. M., & Beatty, J. D. (1984) · The American Journal of Surgery · doi:10.1016/0002-9610(84)90352-0 · Cited by 84
Hartge, P. A., Whittemore, A. S., Itnyre, J., McGowan, L., & Cramer, D. W. (1994) · PubMed · Cited by 83
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer.
Einhorn, N., Sjövall, K., Knapp, R. C., Hall, P., Scully, R. E., Bast, R. C., & Zurawski, V. R. (1992) · PubMed · Cited by 78
Relative risks and benefits of long‐term estrogen replacement therapy: A decision analysis
Gorsky, R. D., Koplan, J. P., Peterson, H. B., & Thacker, S. B. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90483-9 · Cited by 74
The Influence of Diagnostic Radiography on the Incidence of Breast Cancer and Leukemia
Evans, J. S., Wennberg, J. E., & McNeil, B. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609253151306 · Cited by 74
Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer
TEMPLE, W. J., Lindsay, R. L., Magi, E., & Urbanski, S. J. (1991) · The American Journal of Surgery · doi:10.1016/0002-9610(91)91100-w · Cited by 70
Subcutaneous mastectomy: acute complications and long-term follow-up.
Slade, C. L. (1984) · PubMed · Cited by 68
How Best to Teach Women Breast Self-Examination: A Randomized Controlled Trial
Fletcher, S. W., O'Malley, M. S., Earp, J. L., Morgan, T. M., Lin, S., & Degnan, D. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-10-772 · Cited by 67
Screening for Ovarian Cancer: The Preliminary Experience of a Familial Ovarian Cancer Center
Muto, M. G., Cramer, D. W., Brown, D. L., Welch, W. R., Harlow, B. L., Xu, H., Brucks, J. P., Tsao, S., & Berkowitz, R. S. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1239 · Cited by 67
Hicken, N. F. (1940) · Archives of Surgery · doi:10.1001/archsurg.1940.04080010009002 · Cited by 62
The Epidemiology of Ovarian Cancer
Daly, M. B. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30307-1 · Cited by 51
Mettlin, C. J., & Smart, C. R. (1994) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.4.248 · Cited by 45
The role of the nurse-examiner in the National Breast Screening Study.
Miller, A., Baines, C. J., & Turnbull, C. (1991) · PubMed · Cited by 44
Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: Opinion or knowledge?
Humphrey, L. J. (1983) · The American Journal of Surgery · doi:10.1016/0002-9610(83)90188-5 · Cited by 40
Adult T-cell lymphoma in israeli patients of iranian origin
Sidi, Y., Meytes, D., Shohat, B., Fenig, E., Weisbort, Y., Lee, H., Pinkhas, J., & Rosenblatt, J. D. (1990) · Cancer · doi:10.1002/1097-0142(19900201)65:3<439::aid-cncr2820650311>3.0.co;2-w · Cited by 39
MAMMOGRAPHY SCREENING AND THE CONTROVERSY CONCERNING WOMEN AGED 40 TO 49
Kopans, D. B. (1995) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00657-1 · Cited by 35
Recurrent Secretory Carcinoma in Residual Mammary Tissue After Mastectomy
Mies, C. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199307000-00009 · Cited by 34
WHY QUESTION SCREENING MAMMOGRAPHY FOR WOMEN IN THEIR FORTIES?
Fletcher, S. W. (1995) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00656-x · Cited by 33
Chemoprevention of Breast Cancer
O’Shaughnessy, J. (1996) · JAMA · doi:10.1001/jama.1996.03530410063035 · Cited by 30
Pennisi, V. R., Capozzi, A., & Perez, F. M. (1977) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-197701000-00009 · Cited by 30
A reappraisal of prophylactic mastectomy.
Wapnir, I., Rabinowitz, B., & Greco, R. S. (1990) · PubMed · Cited by 28
Breast Reconstruction: Current State of the Art
Woods, J. E. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62008-4 · Cited by 22
Screening in Breast Cancer Families: Is it Useful?
Vasen, H. F. A. (1994) · Annals of Medicine · doi:10.3109/07853899409147888 · Cited by 18
Prophylactic Mastectomy with Immediate Reconstruction for the High-Risk Woman
Leonard, R. (1984) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)31799-5 · Cited by 15
The role of tumour markers in ovarian cancer.
Gargano, G., Correale, M., Abbate, I., Falco, G., Frenza, N. D., Lorusso, V., De Lena, M., & LEONARDIS, A. D. (1990) · PubMed · Cited by 10
Transvaginal sonography as a screening method for ovarian cancer
Higgins, R. V., Nagell, J. V., Donaldson, E. S., Gallion, H. H., Pavlik, E. J., Endicott, B., & Woods, C. (1990) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(90)90928-e · Cited by 7
Subcutaneous Mastectomy: Promises and Pitfalls
Hyland, W. T. (1985) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)43590-5 · Cited by 4
Kopans, D. B. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.5.7717258 · Cited by 3
Ben David, Y., & Shalev, E. (1997) · PubMed · Cited by 1
Cited by
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Self-citationCannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
American Cancer Society Guidelines for the Early Detection of Cancer
Smith, R. A., Cokkinides, V., von Eschenbach, A. C., Levin, B., Cohen, C., Runowicz, C. D., Sener, S., Saslow, D., & Eyre, H. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.8 · Cited by 1,588
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Metadata
- Authors
- Burke, W.
- Corresponding author
- Burke, Wylie
- ORCID
- Burke, Wylie
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-26
- Volume
- 277
- Issue
- 12
- Pages
- 997
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4236095073
- Cited by
- 955
- References
- 114
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 15 · 2015: 11 · 2014: 10 · 2013: 19 · 2012: 15
- FWCI
- 44.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- BRCA1, BRCA2, hereditary breast and ovarian cancer, cancer surveillance, cancer risk reduction, breast cancer screening, ovarian cancer screening, prophylactic surgery, cancer susceptibility
- MeSH terms
- Breast Neoplasms, Contraceptives, Oral, Decision Making, Disease Susceptibility, Female, Genetic Counseling, Genetic Markers, Genetic Testing, Heterozygote, Humans, Life Style, Male, Mammography, Mutation, Neoplasm Proteins, Neoplasms, Hormone-Dependent, Ovarian Neoplasms, Ovariectomy, Prostatic Neoplasms, Risk Factors, Transcription Factors, Colorectal Neoplasms, Estrogen Replacement Therapy, Breast Self-Examination, CA-125 Antigen, Ultrasonography, Doppler, Color, Antineoplastic Agents, Hormonal, Genes, BRCA1, BRCA2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.